pazopanib HCl 400 MG Oral Tablet

RxCUI
867508
RxNorm name
pazopanib HCl 400 MG Oral Tablet
Display name
pazopanib HCl 400 MG Oral Tablet
Full name
pazopanib HCl 400 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
pazopanibPAZOPANIB HYDROCHLORIDETorrent Pharmaceuticals Limited7235fad0-eb5b-4fdf-a362-c8c65c9bfe1d2026-05-11Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 867508

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7235fad0-eb5b-4fdf-a362-c8c65c9bfe1dpazopanib HCl 400 MG Oral TabletSY3These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 200920260511
7235fad0-eb5b-4fdf-a362-c8c65c9bfe1dPAZOPanib 400 MG Oral TabletPSN3These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 200920260511
7235fad0-eb5b-4fdf-a362-c8c65c9bfe1dpazopanib 400 MG Oral TabletSCD3These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 200920260511